Shares surged as Astera Labs kicked off Computex 2026 in Taipei this week, showcasing a full suite of chips that connect GPUs and accelerators inside AI data centers — the critical "plumbing" that makes massive AI clusters actually work. The stock is up ~9.4% to ARS 11,850, erasing a sharp 6.4% drop in the prior session, as investors bet the company's product pipeline positions it squarely in the path of hyperscaler spending.
A Record Quarter Sets the Baseline — And the Bar
Astera Labs posted Q1 2026 revenue of $308.4 million, up 93% year-over-year and 14% sequentially.
Earnings per share of $0.61 crushed the $0.18 consensus forecast.
For Q2, management guided revenue to $355–$365 million, far above the Street's $310.3 million estimate. That guidance is what gives the Computex rally legs: the beat wasn't a one-off, and the company is telling Wall Street growth is accelerating, not plateauing.
The Big Bet: A New High-Speed Fabric Switch Now Shipping
At Computex, Astera is publicly demoing its newest chip — a 320-lane fabric switch designed to replace multiple older switches so that large clusters of AI chips can talk to each other with lower latency. Think of it as a highway interchange for data inside a server rack. This product is shipping now, with a full production ramp planned for the second half of 2026 , targeting a market the company estimates could hit $20 billion by 2030 — four times its own estimate from late 2024. If Astera captures even a modest slice, the revenue trajectory shifts dramatically.
Hyperscaler Partnerships Are the Real Signal
Revenue grew across both its signal-conditioning and switch-fabric product lines, with strong demand from next-generation switching applications and expanding designs across platforms.
RBC Capital raised its price target to $250, citing expected revenue from Amazon's next-generation chip platform by Q3 2026. The breadth of hyperscaler adoption — not a single customer — will determine whether growth sustains.
Margin Pressure Looms Behind the Headlines
Q2 gross margins are guided to roughly 73%, down from 76.4% in Q1, partly due to a non-cash hit from a customer warrant agreement — essentially, a discount given to a big buyer in exchange for volume commitments. The key question is whether new product volumes can grow fast enough to absorb these costs and rising R&D spending. For now, investors are choosing growth over margin concerns, but that trade-off bears close watching.